FDG PET/CT对儿童卵黄囊瘤患者的评估
回顾性分析31例病理确诊卵黄囊瘤患儿共34次PET/CT检查,其中6次用于初始分期、28次用于治疗后评估。PET/CT在再分期中灵敏度100%、特异度85.7%,46.4%的再分期患者根据PET/CT改变了治疗方案;在初始分期中仅略优于常规影像,未改变任何患者的治疗方案。
要点
- 再分期组PET/CT灵敏度100%、特异度85.7%,阳性预测值90.9%、阴性预测值100%。
- 再分期组46.4%的患者根据PET/CT结果改变了治疗方案。
- 初始分期组6例PET/CT均真阳性,但仅比常规影像多检出少数转移灶,未改变治疗方案。
核心结论
- FDG PET/CT在儿童卵黄囊瘤初始分期中仅略优于常规影像,但在治疗后评估中诊断准确度高且对治疗管理影响大。
研究设计与样本
- 回顾性研究,纳入31例病理确诊的儿童卵黄囊瘤患者,共34次PET/CT检查(6次初始分期、28次治疗后评估),由两名核医学医生共识阅片,以组织病理学结合临床和影像随访为参考标准,并与常规影像及α-甲胎蛋白(AFP)水平比较。
诊断标准与关键数值
- 再分期组PET/CT灵敏度100%、特异度85.7%;总体每检查灵敏度100%、特异度85.7%、阳性预测值90.9%、阴性预测值100%;PET/CT在卵黄囊瘤再分期中准确度高于AFP水平。
临床应用与阅片要点
- 再分期组46.4%的患者根据PET/CT结果改变了治疗方案;初始分期组6例PET/CT均真阳性,仅比常规影像多检出少数转移灶,未改变治疗方案。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The objective of our study was to evaluate the clinical utility of FDG PET/CT in staging and restaging pediatric patients with yolk sac tumor (YST). MATERIALS AND METHODS. We retrospectively reviewed the data from 31 pediatric patients with pathologically confirmed YST who underwent 34 PET/CT studies for the purpose of staging or restaging. The PET/CT studies were read by two nuclear medicine doctors in consensus. Histopathology combined with clinical and imaging follow-up was taken as the reference standard. The results of PET/CT were also compared with conventional imaging and α-fetoprotein (AFP) levels when available. RESULTS. Of the total 34 studies, six were performed for initial staging and the other 28 for posttherapy evaluation. FDG PET/CT was true-positive in all six staging studies, detected only a few more metastatic foci than conventional imaging, and changed the therapeutic regimen in none of the six patients. Nevertheless, PET/CT showed high accuracy in the restaging group, with a sensitivity of 100% and specificity of 85.7%. The treatment regimen was changed in 46.4% of the patients in the restaging group according to the PET/CT study. In addition, PET/CT had higher accuracy than AFP levels in YST restaging. Overall, the per-study performance of PET/CT was a sensitivity of 100%, specificity of 85.7%, positive predictive value of 90.9%, and negative predictive value of 100%. CONCLUSION. FDG PET/CT was only slightly superior to conventional imaging in staging YST in pediatric patients. However, PET/CT of posttherapy patients with YST showed high diagnostic accuracy and had a great impact on therapeutic management.
引用
- Tang W, Liu Z, Fu H, et al. FDG PET/CT Evaluation of Pediatric Patients With Yolk Sac Tumor. AJR Am J Roentgenol. 2019. PMID: 31120780. doi:10.2214/AJR.18.20968
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。